Physician profile
Sona A Patel
NPI 1770554834
$1,444.29
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $840 · 2020: $210 · 2021: $124 · 2022: $32.52 · 2023: $137 · 2024: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $301.54 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $188.35 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $179.55 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $129.40 | 2019-2021 | |
| Beta Bionics, INC. | $101.18 | 2024 | Ilet Bionic Pancreas |
| Merck Sharp & Dohme LLC | $99.02 | 2019-2023 | Zerbaxa, Dificid |
| Vifor Pharma, INC. | $81.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $79.26 | 2019-2023 | |
| Abbvie INC. | $46.77 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $39.02 | 2021 | |
| Amgen INC. | $28.72 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $28.08 | 2021-2023 | Nuzyra |
| Allergan, INC. | $27.05 | 2019 | |
| Mallinckrodt Enterprises LLC | $20.19 | 2019 | |
| Genzyme Corporation | $18.17 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.72 | 2019 | |
| Gilead Sciences, INC. | $16.28 | 2021 | |
| Horizon Therapeutics Plc | $15.53 | 2020 | |
| Medtronic USA, INC. | $14.16 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sona Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.